Naples Global Advisors, LLC Eli Lilly & CO Transaction History

Naples Global Advisors, LLC

  • $985 Million
  • Q2 2024

A detailed history of Naples Global Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Naples Global Advisors, LLC holds 12,780 shares of LLY stock, worth $10.1 Million. This represents 1.17% of its overall portfolio holdings.

Number of Shares
12,780
Previous 13,328 4.11%
Holding current value
$10.1 Million
Previous $10.4 Million 11.59%
% of portfolio
1.17%
Previous 1.08%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024
SELL
$724.87 - $909.04 $397,228 - $498,153
-548 Reduced 4.11%
12,780 $11.6 Million
Q1 2024

Apr 29, 2024
SELL
$592.2 - $792.28 $180,621 - $241,645
-305 Reduced 2.24%
13,328 $10.4 Million
Q4 2023

Jan 11, 2024
SELL
$525.19 - $619.13 $335,596 - $395,624
-639 Reduced 4.48%
13,633 $7.95 Million
Q3 2023

Oct 16, 2023
SELL
$434.7 - $599.3 $181,704 - $250,507
-418 Reduced 2.85%
14,272 $7.67 Million
Q2 2023

Jul 17, 2023
BUY
$350.74 - $468.98 $473,148 - $632,654
1,349 Added 10.11%
14,690 $6.89 Million
Q1 2023

Apr 17, 2023
SELL
$310.63 - $364.82 $38,828 - $45,602
-125 Reduced 0.93%
13,341 $4.58 Million
Q4 2022

Jan 20, 2023
SELL
$321.55 - $374.67 $115,758 - $134,881
-360 Reduced 2.6%
13,466 $0
Q3 2022

Oct 20, 2022
SELL
$296.48 - $337.87 $46,843 - $53,383
-158 Reduced 1.13%
13,826 $4.47 Million
Q2 2022

Aug 11, 2022
SELL
$278.73 - $327.27 $1,393 - $1,636
-5 Reduced 0.04%
13,984 $4.53 Million
Q1 2022

Apr 28, 2022
SELL
$234.69 - $291.66 $11,499 - $14,291
-49 Reduced 0.35%
13,989 $4.01 Million
Q4 2021

Feb 04, 2022
SELL
$224.85 - $279.04 $23,609 - $29,299
-105 Reduced 0.74%
14,038 $3.88 Million
Q3 2021

Oct 25, 2021
SELL
$221.6 - $272.71 $65,150 - $80,176
-294 Reduced 2.04%
14,143 $3.27 Million
Q2 2021

Aug 06, 2021
SELL
$180.55 - $233.54 $4,333 - $5,604
-24 Reduced 0.17%
14,437 $3.31 Million
Q1 2021

May 10, 2021
SELL
$164.32 - $212.72 $36,972 - $47,862
-225 Reduced 1.53%
14,461 $2.7 Million
Q4 2020

Feb 08, 2021
SELL
$130.46 - $172.63 $48,792 - $64,563
-374 Reduced 2.48%
14,686 $2.48 Million
Q3 2020

Oct 26, 2020
BUY
$146.22 - $169.13 $7,457 - $8,625
51 Added 0.34%
15,060 $2.23 Million
Q2 2020

Aug 04, 2020
SELL
$136.42 - $164.18 $1,227 - $1,477
-9 Reduced 0.06%
15,009 $2.46 Million
Q1 2020

Apr 27, 2020
SELL
$119.05 - $147.35 $90,716 - $112,280
-762 Reduced 4.83%
15,018 $2.08 Million
Q4 2019

Feb 05, 2020
BUY
$106.92 - $132.43 $17,641 - $21,850
165 Added 1.06%
15,780 $2.07 Million
Q3 2019

Oct 28, 2019
BUY
$106.79 - $116.16 $2,562 - $2,787
24 Added 0.15%
15,615 $1.75 Million
Q2 2019

Jul 10, 2019
BUY
$110.79 - $129.32 $18,834 - $21,984
170 Added 1.1%
15,591 $1.73 Million
Q1 2019

Apr 29, 2019
SELL
$111.31 - $131.02 $11,131 - $13,102
-100 Reduced 0.64%
15,421 $2 Million
Q4 2018

Feb 01, 2019
BUY
$105.9 - $118.64 $17,261 - $19,338
163 Added 1.06%
15,521 $1.8 Million
Q3 2018

Nov 13, 2018
SELL
$85.86 - $107.31 $1,545 - $1,931
-18 Reduced 0.12%
15,358 $1.65 Million
Q2 2018

Jul 23, 2018
BUY
$75.7 - $86.88 $17,411 - $19,982
230 Added 1.52%
15,376 $1.31 Million
Q1 2018

Apr 17, 2018
SELL
$74.21 - $87.6 $5,046 - $5,956
-68 Reduced 0.45%
15,146 $1.17 Million
Q4 2017

Jan 19, 2018
BUY
$81.94 - $87.89 $20,239 - $21,708
247 Added 1.65%
15,214 $1.29 Million
Q3 2017

Oct 16, 2017
BUY
$77.07 - $85.54 $1.15 Million - $1.28 Million
14,967
14,967 $1.28 Million

Others Institutions Holding LLY

# of Institutions
3,775
Shares Held
736M
Call Options Held
7.09M
Put Options Held
7.23M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $751B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Naples Global Advisors, LLC Portfolio

Follow Naples Global Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Naples Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Naples Global Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email